Table 3.
Study design | Cohort | Cross-sectional | Mixed-methods | Secondary cross-sectional | – | – | – | Total |
N | 0 | 3 | 1 | 11 | – | – | – | 15 |
% | 0% | 20% | 7% | 73% | – | – | – | 100% |
Assessment approaches | Clinical only | Self-report only | Functional only | Clinical and self-report | Clinical and functional | Other combination | Secondary sources (multiple) | |
N | 1 | 9 | 0 | 4 | 0 | 1 | 0 | 15 |
% | 7% | 60% | 0% | 27% | 0% | 7% | 0% | 100% |
Participants (N)* | <500 | 500–999 | 1000–4999 | 5000–9999 | 10 000–24 999 | >25 000 | Not available | |
N | 0 | 1 | 4 | 4 | 2 | 4 | 0 | 15 |
% | 0% | 7% | 27% | 27% | 13% | 27% | 0% | 100% |
Age (years) included† | Under 15 | <15 to 85+ | 15 to 85+ | 40 to 85+ | 60 to 85+ | Over 85 | – | |
N | 1 | 3 | 5 | 0 | 5 | 1 | – | 15 |
% | 7% | 20% | 33% | 33% | 33% | 7% | – | 100% |
JBI score | <7 | 7 | 8 | 9 | 10 | – | – | |
N | 0 | 0 | 3 | 5 | 7 | – | – | 15 |
% | 0% | 0% | 20% | 33% | 47% | – | – | 100% |
Mobility functioning difficulty or impairment definition | Use of AP | Reported activity limitations | Clinical threshold | Combination | – | – | – | |
N | 7 | 6 | 0 | 2 | – | – | – | 15 |
% | 47% | 40% | 0% | 13% | – | – | – | 100% |
WHO Region | AFR | AMR | EMR | EUR | SEAR | WPR | Global | |
N | 2 | 10 | 0 | 2 | 2 | 1 | 0 | 17 |
% | 12% | 59% | 0% | 12% | 12% | 6% | 0% | 100% |
AP access indicator | Total need | Met need | Unmet need | Undermet need | Coverage | Use | Has AP | |
N | 3 | 0 | 6 | 1 | 2 | 26 | 4 | 42 |
% | 7% | 0% | 14% | 2% | 5% | 62% | 10% | 100% |
Indicator denominator | Total with/using AP | Total with need | Total with functioning difficulty | Total participants | Total population | – | – | |
N | 3 | 2 | 12 | 19 | 6 | – | – | 42 |
% | 7% | 5% | 29% | 45% | 14% | – | – | 100% |
*Participants (N) ranged from 839 to 66 410 for this domain.
†Age group boundaries varied considerably by study; studies are sorted into categories that most closely represent their included age boundaries.
AFR, African Region; AMR, Region of the Americas; AP, assistive product; EMR, Eastern Mediterranean Region; EUR, European Region; JBI, Joanna Briggs Institute; SEAR, Southeast Asian Region; WPR, Western Pacific Region.